UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Characterization of Cytomegalovirus Breakthrough Events in a Phase 2 Prophylaxis Trial of Letermovir (AIC246, MK 8228)

The Journal of infectious diseases, 2016-01, Vol.213 (1), p.23-30

2016

Volltextzugriff (PDF)

The Novel Anticytomegalovirus Compound AIC246 (Letermovir) Inhibits Human Cytomegalovirus Replication through a Specific Antiviral Mechanism That Involves the Viral Terminase

Journal of Virology, 2011-10, Vol.85 (20), p.10884-10893

2011

Volltextzugriff (PDF)

Definitions of Resistant and Refractory Cytomegalovirus Infection and Disease in Transplant Recipients for Use in Clinical Trials

Clinical infectious diseases, 2019-04, Vol.68 (8), p.1420-1426

2019

Volltextzugriff (PDF)

Geno- and Phenotypic Characterization of Human Cytomegalovirus Mutants Selected In Vitro after Letermovir (AIC246) Exposure

Antimicrobial Agents and Chemotherapy, 2014-01, Vol.58 (1), p.610-613

2014

Volltextzugriff (PDF)

In Vitro and In Vivo Activities of the Novel Anticytomegalovirus Compound AIC246

Antimicrobial Agents and Chemotherapy, 2010-03, Vol.54 (3), p.1290-1297

2010

Volltextzugriff (PDF)

Mutual Interplay between the Human Cytomegalovirus Terminase Subunits pUL51, pUL56, and pUL89 Promotes Terminase Complex Formation

Journal of virology, 2017-06, Vol.91 (12)

2017

Volltextzugriff (PDF)

In Vitro Evaluation of the Activities of the Novel Anticytomegalovirus Compound AIC246 (Letermovir) against Herpesviruses and Other Human Pathogenic Viruses

Antimicrobial Agents and Chemotherapy, 2012-02, Vol.56 (2), p.1135-1137

2012

Volltextzugriff (PDF)

Impact of glycoprotein B genotype and naturally occurring ORF UL56 polymorphisms upon susceptibility of clinical human cytomegalovirus isolates to letermovir

Antiviral research, 2016-08, Vol.132, p.204-209

2016

Volltextzugriff (PDF)

Targeted mutagenesis on PDGFRα-Fc identifies amino acid modifications that allow efficient inhibition of HCMV infection while abolishing PDGF sequestration

PLoS pathogens, 2021-03, Vol.17 (3), p.e1009471

2021

Volltextzugriff (PDF)

Exploring the Human Cytomegalovirus Core Nuclear Egress Complex as a Novel Antiviral Target: A New Type of Small Molecule Inhibitors

Viruses, 2021-03, Vol.13 (3), p.471

2021

Volltextzugriff (PDF)

Properties of Oligomeric Interaction of the Cytomegalovirus Core Nuclear Egress Complex (NEC) and Its Sensitivity to an NEC Inhibitory Small Molecule

Viruses, 2021-03, Vol.13 (3), p.462

2021

Volltextzugriff (PDF)

Cellular p32 Recruits Cytomegalovirus Kinase pUL97 to Redistribute the Nuclear Lamina

The Journal of biological chemistry, 2005-09, Vol.280 (39), p.33357-33367

2005

Volltextzugriff (PDF)

The UL69 Transactivator Protein of Human Cytomegalovirus Interacts with DEXD/H-Box RNA Helicase UAP56 To Promote Cytoplasmic Accumulation of Unspliced RNA

Molecular and Cellular Biology, 2006-03, Vol.26 (5), p.1631-1643

2006

Volltextzugriff (PDF)

The cellular DExD/H-box RNA-helicases UAP56 and URH49 exhibit a CRM1-independent nucleocytoplasmic shuttling activity

PloS one, 2011-07, Vol.6 (7), p.e22671

2011

Volltextzugriff (PDF)

Inhibition of Human Cytomegalovirus Replication via Peptide Aptamers Directed against the Nonconventional Nuclear Localization Signal of the Essential Viral Replication Factor pUL84

Journal of Virology, 2009-11, Vol.83 (22), p.11902-11913

2009

Volltextzugriff (PDF)

Human Cytomegalovirus UL84 Protein Contains Two Nuclear Export Signals and Shuttles between the Nucleus and the Cytoplasm

Journal of Virology, 2006-10, Vol.80 (20), p.10274-10280

2006

Volltextzugriff (PDF)

Sox10 Is an Active Nucleocytoplasmic Shuttle Protein, and Shuttling Is Crucial for Sox10-Mediated Transactivation

Molecular and Cellular Biology, 2002-08, Vol.22 (16), p.5826-5834

2002

Volltextzugriff (PDF)

In vitro drug combination studies of Letermovir (AIC246, MK-8228) with approved anti-human cytomegalovirus (HCMV) and anti-HIV compounds in inhibition of HCMV and HIV replication

Antimicrobial agents and chemotherapy, 2015-06, Vol.59 (6), p.3140-3148

2015

Volltextzugriff (PDF)

A Nonconventional Nuclear Localization Signal within the UL84 Protein of Human Cytomegalovirus Mediates Nuclear Import via the Importin α/β Pathway

Journal of Virology, 2003-03, Vol.77 (6), p.3734-3748

2003

Volltextzugriff (PDF)

Phenotypic characterization of two naturally occurring human Cytomegalovirus sequence polymorphisms located in a distinct region of ORF UL56 known to be involved in in vitro resistance to letermovir

Antiviral research, 2015-04, Vol.116, p.48-50

2015

Volltextzugriff (PDF)

Antiviral strategies to combat cytomegalovirus infections in transplant recipients

Current opinion in pharmacology, 2008-10, Vol.8 (5), p.541-548

2008

Volltextzugriff (PDF)

Targeted mutagenesis on PDGFR[alpha]-Fc identifies amino acid modifications that allow efficient inhibition of HCMV infection while abolishing PDGF sequestration

PLoS pathogens, 2021-03, Vol.17 (3)

2021

Volltextzugriff (PDF)

Letermovir for Cytomegalovirus Prophylaxis in Hematopoietic-Cell Transplantation

The New England journal of medicine, 2014-05, Vol.370 (19), p.1781-1789

2014

Volltextzugriff (PDF)

Intercultural Competencies in China

1st ed., 2017

Volltextzugriff (PDF)

Preemptive treatment of Cytomegalovirus infection in kidney transplant recipients with letermovir: results of a Phase 2a study

Transplant international, 2014-01, Vol.27 (1), p.77-86

2014

Volltextzugriff (PDF)

1 – 25 von 121

Suche als RSS-Feed

Aktive Filter

KollektionAIP Journals Complete

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(74)
Mit Volltextzugriff
(116)

Publikationsform

Sprache

Englisch
(94)
Deutsch
(28)
Japanisch
(18)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Characterization of Cytomegalovirus Breakthrough Events in a Phase 2 Prophylaxis Trial of Letermovir (AIC246, MK 8228)

The Novel Anticytomegalovirus Compound AIC246 (Letermovir) Inhibits Human Cytomegalovirus Replication through a Specific Antiviral Mechanism That Involves the Viral Terminase

Definitions of Resistant and Refractory Cytomegalovirus Infection and Disease in Transplant Recipients for Use in Clinical Trials

Geno- and Phenotypic Characterization of Human Cytomegalovirus Mutants Selected In Vitro after Letermovir (AIC246) Exposure

In Vitro and In Vivo Activities of the Novel Anticytomegalovirus Compound AIC246

Mutual Interplay between the Human Cytomegalovirus Terminase Subunits pUL51, pUL56, and pUL89 Promotes Terminase Complex Formation

In Vitro Evaluation of the Activities of the Novel Anticytomegalovirus Compound AIC246 (Letermovir) against Herpesviruses and Other Human Pathogenic Viruses

Impact of glycoprotein B genotype and naturally occurring ORF UL56 polymorphisms upon susceptibility of clinical human cytomegalovirus isolates to letermovir

Targeted mutagenesis on PDGFRα-Fc identifies amino acid modifications that allow efficient inhibition of HCMV infection while abolishing PDGF sequestration

Exploring the Human Cytomegalovirus Core Nuclear Egress Complex as a Novel Antiviral Target: A New Type of Small Molecule Inhibitors

Properties of Oligomeric Interaction of the Cytomegalovirus Core Nuclear Egress Complex (NEC) and Its Sensitivity to an NEC Inhibitory Small Molecule

Cellular p32 Recruits Cytomegalovirus Kinase pUL97 to Redistribute the Nuclear Lamina

The UL69 Transactivator Protein of Human Cytomegalovirus Interacts with DEXD/H-Box RNA Helicase UAP56 To Promote Cytoplasmic Accumulation of Unspliced RNA

The cellular DExD/H-box RNA-helicases UAP56 and URH49 exhibit a CRM1-independent nucleocytoplasmic shuttling activity

Inhibition of Human Cytomegalovirus Replication via Peptide Aptamers Directed against the Nonconventional Nuclear Localization Signal of the Essential Viral Replication Factor pUL84

Human Cytomegalovirus UL84 Protein Contains Two Nuclear Export Signals and Shuttles between the Nucleus and the Cytoplasm

Sox10 Is an Active Nucleocytoplasmic Shuttle Protein, and Shuttling Is Crucial for Sox10-Mediated Transactivation

In vitro drug combination studies of Letermovir (AIC246, MK-8228) with approved anti-human cytomegalovirus (HCMV) and anti-HIV compounds in inhibition of HCMV and HIV replication

A Nonconventional Nuclear Localization Signal within the UL84 Protein of Human Cytomegalovirus Mediates Nuclear Import via the Importin α/β Pathway

Phenotypic characterization of two naturally occurring human Cytomegalovirus sequence polymorphisms located in a distinct region of ORF UL56 known to be involved in in vitro resistance to letermovir

Antiviral strategies to combat cytomegalovirus infections in transplant recipients

Targeted mutagenesis on PDGFR[alpha]-Fc identifies amino acid modifications that allow efficient inhibition of HCMV infection while abolishing PDGF sequestration

Letermovir for Cytomegalovirus Prophylaxis in Hematopoietic-Cell Transplantation

Intercultural Competencies in China

Preemptive treatment of Cytomegalovirus infection in kidney transplant recipients with letermovir: results of a Phase 2a study

Aktive Filter

Suchergebnisse filtern